Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

SEMAGLUTIDE

FDA · NDA · 2026-08-27

AgencyFDA
Submission typeNDA
Action date2026-08-27
BrandOZEMPIC
SponsorNOVO
RouteSUBCUTANEOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:58.877Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:SEMAGLUTIDE:2026-08-27

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

SEMAGLUTIDE — approval | AEaH